Skip to content

impact of vancomycin in prevention of endophthalmitis

Effect of using vancomycin during Cataract Operation in preventing endophthalmitis patients after Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012112611581N1
Enrollment
1281
Registered
2013-03-03
Start date
2011-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Senile Cataract

Interventions

Intervention 1: Interventional Group: adding 1mg vancomycine drug in in 500cc for washing patients`eye during cataract surgery. Intervention 2: Control group: only 500 cc of Ringer's saline without a
Treatment - Drugs
Placebo
Interventional Group: adding 1mg vancomycine drug in in 500cc for washing patients`eye during cataract surgery.
Control group: only 500 cc of Ringer's saline without added drug was used for washing the eye during cataract surgery

Sponsors

Arak university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 87 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included patients: cataract, absence of heart disease - lung, lack of sensitivity to Vankomaysine not Pernyt risk of glaucoma and other inflammatory diseases were also treated patients who experienced complications during surgery or traumatic cataract or cataract Sayrbymaryhay with intraocular inflammatory diseases such as uveitis or glaucoma or other eye were excluded from the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Endophthalmitis. Timepoint: until two weeks after Cataract surgery. Method of measurement: examination with slitlamp.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Rahmat Allah Jadidi

Arak University of Medical Science

jadidi88@gmail.com+98 86 1417 3641

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026